The "Series of Academic Meetings on New Advances in the Treatment of Relapsed/Refractory Multiple Myeloma," hosted by the Chengdu High-tech Medical Association, were successfully held from July to September 2025. The meetings focused on the latest developments and clinical challenges in RRMM, facilitating in-depth exchanges and discussions on core topics such as new treatment strategies and the application of innovative drugs. Participating experts shared valuable experiences, reached consensus on promoting treatment standardization and exploring better clinical solutions, which has effectively promoted the enhancement and development of hematology diagnosis and treatment levels in the region.